SSGI Inc. (OTCMKTS:VICP – Get Free Report) shares dropped 41.2% during mid-day trading on Tuesday. The stock traded as low as $0.30 and last traded at $0.50. Approximately 7,900 shares traded hands during mid-day trading, an increase of 2,388% from the average session volume of 318 shares. The stock had previously closed at $0.85.
SSGI Trading Up 21.4%
The stock has a market cap of $27.26 million, a P/E ratio of -28.33 and a beta of 4.63. The firm has a 50-day simple moving average of $1.26 and a two-hundred day simple moving average of $1.38.
SSGI Company Profile
Vicapsys Life Sciences, Inc focuses on the development and commercialization of VICAPSYN, a proprietary product. The company’s product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc and changed its name to Vicapsys Life Sciences, Inc in September 2017.
Read More
- Five stocks we like better than SSGI
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for SSGI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SSGI and related companies with MarketBeat.com's FREE daily email newsletter.
